Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 467 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Pain Clear all

Conditions: Lumbar Spondylosis
Interventions: Angel® Concentrated Platelet Rich Plasma System, Platelet Rich Plasma; Device · Drug
Lead sponsor: Matthew Pingree; Other
Eligibility: 22 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Osteoarthritis, Tendinitis, Sports Injury, Degenerative Disc Disease, Degenerative Arthritis, Ligament Injury, Neuropathy, Pelvic Pain
Interventions: Umbilical Allograft; Other
Lead sponsor: R3 Stem Cell; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Encino, California

Conditions: Hip Disease, Hip Fractures, Hip Injuries, Hip Arthritis, Hip Pain Chronic
Interventions: M/L Taper with Kinectiv Technology Stems and Necks; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Musculoskeletal Complications, Pain, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: naproxen, placebo; Drug · Other
Lead sponsor: Gary Morrow; Other
Eligibility: 18 Years to 120 Years
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 16
States / cities: Honolulu, Hawaii • Decatur, Illinois • Evanston, Illinois + 13 more

Conditions: Scoliosis, Pain
Interventions: Methadone, Normal Saline, Morphine; Drug · Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 10 Years to 18 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Coronary Artery Disease, Angina Pectoris, Cardiac Valve Disease
Interventions: SternaLock Blue closure system, Suture Wire; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 12
States / cities: Jacksonville, Florida • Orlando, Florida • Atlanta, Georgia + 8 more

Conditions: Distal Radius Fractures
Interventions: Hematoma Local Anesthetic Block Procedure with 1% Lidocaine, Bier Anesthetic Block Procedure with 1% Lidocaine; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Kidney Cancer, Melanoma (Skin), Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: cryosurgery, radiation therapy; Procedure · Radiation
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 7
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Jacksonville, Florida + 3 more

Conditions: Spinal Disease, Spinal Radiculopathy, Myelopathy, Neurogenic Claudication
Interventions: treatment plan; Other
Lead sponsor: Carolina Neurosurgery & Spine Associates; Other
Eligibility: 18 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Breast Cancer, Multiple Myeloma, Prostate Cancer
Interventions: zoledronic acid; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2002
U.S. locations: 7
States / cities: Stockton, California • Kissimmee, Florida • Las Vegas, Nevada + 3 more

Conditions: Pain, Postoperative, Pain, Acute Postoperative, Ankle Fractures, Ankle Injuries and Disorders
Interventions: Exparel, Peripheral Nerve Block; Drug
Lead sponsor: St. Luke's Hospital, Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Bethlehem, Pennsylvania

Conditions: Opioid Use, Fractures, Bone, Trauma
Interventions: Narcotic pain medication, Nonnarcotic pain medications; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pain, Acute
Interventions: Ketamine, Morphine; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Degenerative Disc Disease
Interventions: Single Dose MPCs Injection, Single injection of saline solution, Single injection of hyaluronic acid; Biological · Procedure
Lead sponsor: Mesoblast, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 13
States / cities: Scottsdale, Arizona • Sacramento, California • Santa Monica, California + 10 more

Conditions: Cleft Lip and Palate
Interventions: Liposomal Bupivacaine, Bupivacain, Epinephrine; Drug
Lead sponsor: Kerry O'Rourke; Other
Eligibility: 6 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Bone Ingrowth, Pain
Interventions: Celecoxib; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 95 Years · Male only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pectus Excavatum
Interventions: Patient controlled analgesia, Continuous thoracic epidural infusions, Continuous paravertebral blockade; Device · Procedure
Lead sponsor: Ralph Beltran; Other
Eligibility: Not listed
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Bone Metastases in the Thorax
Interventions: FLASH Radiotherapy; Radiation
Lead sponsor: Varian, a Siemens Healthineers Company; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Peoria, Illinois • Cincinnati, Ohio

Conditions: Bone Sarcoma, Childhood Cancer
Interventions: Cognitive Behavior Therapy, Transcranial Direct Current Stimulation, Placebo Administration, Questionnaire Administration, Interview; Behavioral · Device · Drug + 1 more
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 10 Years and older
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Stomatitis
Interventions: Etanercept, Placebo; Drug
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: 16 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 2
States / cities: Bethesda, Maryland • Greenville, South Carolina

Conditions: Type 2 Diabetes, Neuropathy, Painful, Chronic Low-back Pain, Lumbar Disc Herniation
Interventions: Not listed
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Vertebral Compression, Vertebra Compression Fracture, Vertebral Fracture
Interventions: Basivertebral nerve block, Lidocaine induced basivertebral nerve block; Procedure · Drug
Lead sponsor: Northwell Health; Other
Eligibility: 50 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Port Jefferson, New York

Conditions: Spinal Cord Injuries, Neuropathic Pain, Degenerative Disc Disease, Spinal Stenosis, Spondylosis
Interventions: EC5026 oral tablet, Placebo oral tablet; Drug
Lead sponsor: EicOsis Human Health Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Chronic Ischemic Heart Disease, Left Ventricular Dysfunction, Angina, Ischemic Cardiomyopathy
Interventions: Adult stem cells, Placebo; Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 5
States / cities: Gainesville, Florida • Minneapolis, Minnesota • Cleveland, Ohio + 2 more

Search by objective public record fields.

Study Evaluating the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain

Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

MDR - M/L Taper With Kinectiv Technology Stems and Necks

Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)

Perioperative Methadone Use to Decrease Opioid Requirement in Pediatric Spinal Fusion Patients

An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery

Hematoma Block Versus Bier Block for Closed Fracture Reduction

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery

Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures

Comparison of Low-dose Ketamine to Opioids in the Management of Acute Pain in Patients Presenting to the Emergency Department With Long Bone Fractures

Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain

Liposomal Bupivacaine Use in Alveolar Bone Graft Patients

The Effects of Celecoxib on Bone Ingrowth

Nuss Procedure: Clinical Options in Pediatric Pain Management?

FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax

Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

Methylglyoxal Evaluation in Humans

Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)